off label glp 1 GLP-1 “microdosing” usually means starting below standard dosing and increasing more slowly. Some people consider it to reduce nausea or other side effects, lower cost, or ease into treatment. But it is or just taking back control—GLP Striking disparities in off-label GLP-1

Courts across the country have consolidated many of these cases into multidistrict litigation (MDL) to manage the volume of claims efficiently

With continued use, the gastric-emptying effect may diminish somewhat (tachyphylaxis), though other metabolic benefits persist

34,35 Subsequently, GLP-1 undergoes enzymatic degradation facilitated by dipeptidyl peptidase IV (DPP-4), leading to the loss of its biological efficacy

Because these medications can play an important role in obesity treatment and blood sugar management, knowing how to use, store, and source them correctly can affect both results and cost

According to the ASA and AANA Closed Claims Projects, pulmonary aspiration of gastric contents is one of the top three serious, sometimes catastrophically adverse events that occur during anesthesia care